Site Map
|
Contact Us
|
Bookmark
Single Disease Educational Content
Multi-Disease
Educational Content
Other Resources
About CLDF
Laparoscopy for liver malignancy oncologically safe: study
01-31-2012
U.S. hepatitis A vaccine rates vary widely
01-25-2012
Four-drug therapy wiped out hepatitis C virus in most cases
01-18-2012
Rituximab helpful against HCV cryoglobulinemic vasculitis
01-13-2012
View Complete News Library
View content by clicking on a disease specific area listed above
Reporting
on HBV
from DDW
Reporting
on HBV
from EASL
Reporting
on HBV
AASLD
Abstract Review
HBeAG(+)
Patient
Entecavir
and IFN
HBeAG(-)
Patient
View Meeting details!
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3
Viral hepatitis B, active component, U.S. Armed Forces, 2000-2010
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
View All Articles
February 16-19
The 22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL 2012)
Taipei, Taiwan
February 24-27
CDDW: Canadian Digestive Diseases Week and Annual Canadian Association for the Study of the Liver (CASL) Winter Meeting
Montreal, Quebec
February 29 - March 1
EASL Basic School of Hepatology Course 7: Hepatocyte Damage & Liver Metabolism
Trieste, Italy
March 1-4
Mayo Clinic Gastroenterology and Hepatology 2012
Coronado, CA
March 14-16
1st F.O.C.H Forum on Chronic Hepatitis
Rome, Italy
March 31 - April 1
27th Annual New Treatments in Chronic Liver Disease-Scripps Clinic
San Diego, CA
View All Conventions
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2011 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource
for US healthcare providers only. Use of this Web site is governed by the CLD Foundation
terms of use
and
privacy statement
.